Saturday 17 October 2026
Export ORIC’s income statement to Excel — free account
Oric Pharmaceuticals, Inc.
ORIC Healthcare Biotechnology
In the quarter to June 2026, EPS grew 19.2% and free cash flow fell 3.42%, each against the same quarter a year earlier.
12.35
0.42
−3.29%
Follow ORIC
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Current Ratio |
+8 more quarters Free account |
14.65 | 14.13 | 16.33 | 13.19 |
Net Debt/EBITDA |
7.77 | 8.17 | 7.19 | 5.92 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.77 | 0.74 | 0.91 | 0.76 | |
Capex/Depreciation |
0.12 | (2.84) | 0.00 | (0.64) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.25) | (0.26) | (0.31) | (0.30) | |
Cash per Share |
2.90 | 3.21 | 2.67 | 2.45 | |
Shareholders Equity per Share |
4.11 | 4.38 | 3.94 | 3.53 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
4.11 | 4.38 | 3.94 | 3.53 | |
Free Cash Flow |
(25.15) | (22.71) | (32.44) | (31.96) | |
Working Capital |
275.42 | 268.05 | 272.46 | 252.94 | |
Capital Expenditures |
(0.03) | (0.23) | 0.00 | (0.36) | |
Net Current Asset Value |
271.32 | 263.94 | 269.03 | 250.27 | |
| Other line items | |||||
Quick Ratio |
14.23 | 13.79 | 15.86 | 12.76 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.25) | (0.26) | (0.31) | (0.29) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Payables |
3.57 | 2.69 | 4.03 | 3.50 | |
Average Assets |
366.63 | 341.52 | 339.81 | 375.77 | |
Average Common Equity |
340.46 | 313.74 | 317.65 | 352.63 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates